O-Negative Whole Human Blood for Emergencies
Universal donor O-negative whole human blood, group-typed and cross-matched, for immediate use in trauma cases without compatibility testing. HTS 3002.90.52.10 covers this as therapeutic whole human blood not separated into fractions.
Import Duty Rates by Country of Origin
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If prepared for diagnostic lab testing
Whole blood specifically for in-vitro diagnostic uses (not therapeutic transfusion) falls under diagnostic preparations.
If used as diagnostic reagent in measured doses
Chapter note excludes diagnostic reagents of 3822; blood prepared solely for lab diagnostics shifts there.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• File FDA Prior Notice via ACE system at least 72 hours before arrival with detailed product and shipper info
• Partner with licensed blood banks for import; ensure compliance with 21 CFR 640 standards for processing and labeling
• Beware of short shelf life (21-35 days); plan expedited customs to avoid expiration-related rejections
Related Products under HTS 3002.90.52.10
Whole Human Blood for Transfusion
Whole human blood collected from donors, anticoagulated, and prepared for direct transfusion into patients experiencing acute blood loss or anemia. It falls under HTS 3002.90.52.10 as whole human blood intended for therapeutic uses without separation into components like plasma or platelets.
Anticoagulated Whole Human Blood Units
Standard 450-500mL units of human whole blood treated with CPD or CPDA-1 anticoagulant, stored in PVC blood bags for emergency transfusions. Classified under HTS 3002.90.52.10 as unmodified whole human blood for therapeutic transfusion purposes.
Irradiated Whole Human Blood for Immunocompromised Patients
Gamma-irradiated whole human blood to prevent graft-vs-host disease in transplant or cancer patients, qualifying as therapeutic whole human blood under HTS 3002.90.52.10.
Leukoreduced Whole Human Blood
Whole human blood with leukocytes filtered to <5x10^6 per unit to reduce transfusion reactions, still classified as whole blood under HTS 3002.90.52.10 since primary components remain intact.